Stocktwits on MSN

Tempus AI expands cancer platform with launch of ArteraAI prostate test for metastatic patients

Tempus AI is expanding its clinical oncology offering with the launch of ArteraAI Prostate Test for metastatic hormone-sensitive prostate cancer. ・The tool combines digital pathology and genomic ...
TMCnet

MicroAlgo Inc. Develops Multi-Objective Evolutionary Algorithm to Advance Quantum Circuit Innovation

MicroAlgo Inc. (the "Company" or "MicroAlgo") (NASDAQ: MLGO), today announced the proposal of a powerful solution—a multi-objective evolutionary search strategy, which is an innovative automated tool ...